Clinical Trials Browser

Phase 1/2 × OTHER × nedaplatin × Clear all

NCT06010212 2023-08-24

Fruquintinib as First Line Treatment in Patients With Recurrent Esophageal Squamous Cell Carcinoma

Phase 1/2 Not yet recruiting

Gastrointestinal

Esophageal Squamous Cell Carcinoma

NCT01712919 2014-03-24

Chemoradiation Plus Weekly c225 Against Locoregionally Advanced Nasopharyngeal Carcinoma (NPC)

Phase 1/2 Completed

Nasopharyngeal Carcinoma